Hi, what are you looking for?
Red Metal Resources Ltd. (CSE: RMES,OTC:RMESF) (OTC Pink: RMESF) (FSE: I660) (‘Red Metal’ or the ‘Company’) is pleased to announce a financing. Private placement offering Red Metal...
Green Technology Metals(GT1:AU) has announced EDC Extends LOI for Seymour Lithium Project of up to C$100m Download the PDF here. This post appeared first...
West High Yield (W.H.Y.) Resources Ltd. (TSXV: WHY,OTC:WHYRF) (FSE: W0H) (the ‘Company’ or ‘West High Yield’) announces that it is closing a single tranche (the...
Sranan Gold Corp. (CSE: SRAN,OTC:SRANF) (OTCQB: SRANF) (‘Sranan Gold’ or the ‘Company’) announces that its common shares have been approved for trading on the...
International Lithium Corp. (TSXV: ILC,OTC:ILHMF) (OTCQB: ILHMF) (FSE: IAH) (the ‘Company’ or ‘ILC’) announces that on December 24, 2025, it received the arbitration determination...
Apollo Silver Corp. (‘Apollo Silver’ or the ‘Company’) (TSX.V:APGO, OTCQB:APGOF, Frankfurt:6ZF) is pleased to announce that it has upsized its previously announced non-brokered private...
Nine Mile Metals LTD. (CSE: NINE,OTC:VMSXF) (OTC Pink: VMSXF) (FSE: KQ9) (the ‘Company’ or ‘Nine Mile’) is pleased to announce Certified Assay results for...
Blackstone Minerals (BSX:AU) has announced Managing Director Resignation and Board Changes Download the PDF here. This post appeared first on investingnews.com
Don Durrett: Gold, Silver Price Targets and 15 ‘Must-Own’ Silver Stocks Kicking off the list in the fifth spot is Don Durrett of GoldStockData.com....
Jeffrey Christian, managing partner at CPM Group, shares his outlook for gold and silver in 2026, explaining why he expects higher prices for the...
Altius Minerals (TSX:ALS,OTCQX:ATUSF) is making a bet on a lithium market recovery, agreeing to acquire Lithium Royalty (TSX:LIRC) in a C$520 million deal that...
Craig Hemke, publisher of TFMetalsReport.com, shares his thoughts on the gold and silver markets heading into 2026, outlining why he remains bullish. ‘Just keep...
The biotech sector is entering 2026 with a positive outlook, characterized by reasonable valuations, robust oncology momentum and supportive policy tailwinds. This combination is...